RNAC Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Cartesian Therapeutics Inc (RNAC) Moving Averages Convergence Divergence (MACD) indicator is 0.161, suggesting RNAC is Buy.

Cartesian Therapeutics Inc (RNAC) 20-Day simple moving average is 6.969, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it Buy.

Cartesian Therapeutics Inc (RNAC) 60-Day simple moving average is 7.237, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it Buy.

Technical Analysis for RNAC

Technical Sentiment Analysis for Cartesian Therapeutics Inc (RNAC) As of 2026-03-03, Cartesian Therapeutics Inc (RNAC) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 9 technical signals, shows that 6 indicators are flashing buy, while 3 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for RNAC stands at 54.641, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.161, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 62.837 and the Commodity Channel Index (CCI) at 69.336 further confirm a 0.73 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, RNAC is trading below its 60-day moving average of $7.237 and below its 200-day long-term moving average of $9.217. Key price levels to watch include the immediate resistance at $8.509 and strong support at $6.169. A break above $8.509 could signal a bull continuation, while falling below $6.169 may test the next Fibonacci floor at $4.96.

Cartesian Therapeutics Inc (RNAC) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	3.829	4.96	6.169	7.3	8.509	9.64	10.849
Fibonacci	4.96	5.854	6.406	7.3	8.194	8.746	9.64

Cartesian Therapeutics Inc (RNAC) Technical Indicators

2026-03-03

Name	Value
RSI_14	54.641
STOCHk_14_3_3	62.837
STOCHd_14_3_3	72.896
CCI_20	69.336
AO_5_34	0.59
MOM_10	0.73
MACD_12_26_9	0.161

Cartesian Therapeutics Inc (RNAC) Relative Strength Index (RSI) is 54.641, creating a Neutral signal.

Cartesian Therapeutics Inc (RNAC) Stochastic Oscillator is 62.837, creating a Neutral signal.

Cartesian Therapeutics Inc (RNAC) Stochastic RSI is 72.896, creating a Neutral signal.

Cartesian Therapeutics Inc (RNAC) Commodity Channel Index (CCI) is 69.336, creating a Neutral signal.

Cartesian Therapeutics Inc (RNAC) Awesome Oscillator is 0.59, creating a Buy signal.

Cartesian Therapeutics Inc (RNAC) Momentum is 0.73, creating a Buy signal.

Cartesian Therapeutics Inc (RNAC) MACD is 0.161, creating a Buy signal.

Cartesian Therapeutics Inc (RNAC) Moving Average

2026-03-03

Period	Simple	Signal
MA_5	7.782	Sell
MA_10	7.379	Buy
MA_20	6.969	Buy
MA_60	7.237	Buy
MA_200	9.217	Sell
MA_250	9.988	Sell

Cartesian Therapeutics Inc (RNAC) 5-Day simple moving average is 7.782, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it a Sell.

Cartesian Therapeutics Inc (RNAC) 10-Day simple moving average is 7.379, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it a Buy.

Cartesian Therapeutics Inc (RNAC) 20-Day simple moving average is 6.969, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it a Buy.

Cartesian Therapeutics Inc (RNAC) 60-Day simple moving average is 7.237, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it a Buy.

Cartesian Therapeutics Inc (RNAC) 200-Day simple moving average is 9.217, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it a Sell.

Cartesian Therapeutics Inc (RNAC) 250-Day simple moving average is 9.988, while Cartesian Therapeutics Inc (RNAC) share price is $7.48, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for RNAC?

The overall technical consensus for Cartesian Therapeutics Inc (RNAC) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 0 sell signals.

What are the key support and resistance levels for Cartesian Therapeutics Inc (RNAC) today?

Based on pivot point calculations, Cartesian Therapeutics Inc (RNAC) has an immediate support level at 6.169 and a major resistance level at 8.509. Traders also monitor the pivot point at 7.3 to determine the intraday trend direction.

Is Cartesian Therapeutics Inc (RNAC) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Cartesian Therapeutics Inc (RNAC) is currently 54.641. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Cartesian Therapeutics Inc (RNAC)?

Cartesian Therapeutics Inc (RNAC) Moving Averages Convergence Divergence (MACD) indicator is 0.161, suggesting RNAC is Buy. This indicator helps identify potential trend reversals or momentum shifts for Cartesian Therapeutics Inc.

How is Cartesian Therapeutics Inc (RNAC) performing relative to its 200-day moving average?

Cartesian Therapeutics Inc (RNAC) is currently trading at $7.48, which is below its 200-day simple moving average of 9.217. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.